Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease
Abstract Chronic liver disease leads to neuropsychiatric complications called hepatic encephalopathy (HE). Current treatments have some limitations in their efficacy and tolerability, emphasizing the need for alternative therapies. Modulation of gut bacterial flora using probiotics is emerging as a...
Guardado en:
Autores principales: | Veronika Rackayová, Emmanuelle Flatt, Olivier Braissant, Jocelyn Grosse, Daniela Capobianco, Paola Mastromarino, Matthew McMillin, Sharon DeMorrow, Valérie A. McLin, Cristina Cudalbu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0dc264157648428ea4c3489515746c49 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE
por: Emmanuelle Flatt, et al.
Publicado: (2021) -
Ghrelin reverses ductular reaction and hepatic fibrosis in a rodent model of cholestasis
por: Anca D. Petrescu, et al.
Publicado: (2020) -
Approach to Neurological Channelopathies and Neurometabolic Disorders in Newborns
por: Inn-Chi Lee
Publicado: (2021) -
The Genetics of Inherited Cholestatic Disorders in Neonates and Infants: Evolving Challenges
por: Rebecca Jeyaraj, et al.
Publicado: (2021) -
Lipoid Congenital Adrenal Hyperplasia with Cholestatic Jaundice
por: A Homaei, et al.
Publicado: (2021)